Clinical Trial Update: Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of bone marrow-derived mononuclear cells (BMMNC) for retinitis pigmentosa, sponsored by Chaitanya …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• BMMNC (Bone Marrow Mononuclear Cells) (bone marrow mononuclear cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: UNKNOWN